Emma Doughty
@emmadoughty.bsky.social
230 followers 540 following 24 posts
Genomicist 🧬 at the intersection of bioinformatics 💻, epidemiology🫂 and global public health 🌍
Posts Media Videos Starter Packs
Reposted by Emma Doughty
sequity.bsky.social
Genomic data is powerful only when reliable.

The 6Cs of quality—completeness, continuity, collinearity, correctness, contamination, concordance—show where things go wrong and how errors ripple downstream.

Check out our latest blog post to learn more:
A Genomic Data Quality Framework: The 6Cs and Downstream Consequences
This Genomic Data Quality Framework provides a basis for genomic quality control and laboratory process improvement
tinyurl.com
emmadoughty.bsky.social
Thanks, Marc! I really appreciate your support
emmadoughty.bsky.social
Thanks, Arnoud! I’ve been doing similar work in lots of different contexts already, but Sequity is an exciting new challenge. And training has become my forte over the years - I’ve long lost count of the workshops I’ve led!
emmadoughty.bsky.social
I’m deeply passionate about this, and I can’t wait to share more over the coming weeks.
👉 Follow @sequity.bsky.social for updates
👉 Message me if you’re curious
emmadoughty.bsky.social
Whether you’re starting your first project or scaling to many thousands of samples per month, we work shoulder-to-shoulder with you to define genomics strategy, build resources, train staff, and make it happen.
emmadoughty.bsky.social
That’s why I’m launching Sequity- your partner to turn genomics goals into real, impactful outcomes, in a way that’s both accessible and sustainable.
emmadoughty.bsky.social
I’ve got something exciting to share. After years of working with labs around the world, I’m starting something new!

I’ve seen how many labs want to do more with genomics, but the path forward isn’t always clear. The process is complex, and without the right guidance, it’s easy to get stuck.
The words "INTRODUCING Sequity" and "Your Partner for Microbial Genomics" are shown with the Sequity logo. Above this text is an illustration of four people in a lab setting working with equipment and a laptop. At the top there is a map of the world showing pins and illustrations of hospitals and laboratories. The text reads

SEQUITY MAKES GENOMICS WORK FOR YOU
Developing solutions that work with your unique lab, challenges and epidemiology
CONTEXT-DRIVEN
Delivering outcomes aligned with your objectives
GOAL-ORIENTED This image is text only. This reads,
YOUR PARTNER FOR GENOMICS SUCCESS
STRATEGY
Figuring out what will work in your unique context
RESOURCES
Developing everything- from bioinformatics workflows to SOPs
TRAINING
Ensuring you have the knowledge and skills to deliver
ON-DEMAND SUPPORT
Ongoing support through the day-to-day

An abstract image at the bottom shows scientists working through a process, generating ideas. The text at the top reads,
FROM IDEA TO IMPACT
END-TO-END SUPPORT
From study design to sample, wet lab, bioinformatic, and reporting

VALUED-OUTCOMES
Unlock information and real-world impact
Reposted by Emma Doughty
josephmarcusid.medsky.social
Since it is that time of year:

One of the most rewarding parts of being faculty is paying forward mentorship with students, residents+ fellows for their research projects. So far, as 4th year faculty, I’ve mentored ~40 trainee projects (17 completed). Here are what I talk about at 1st meeting:
a man in a suit and bow tie stands in front of a table full of measuring cups and boxes that say in the name of science
ALT: a man in a suit and bow tie stands in front of a table full of measuring cups and boxes that say in the name of science
media.tenor.com
emmadoughty.bsky.social
Answer: Countries that are high on the Welcoming Countries Rankings and where logistics would be great for hosting conferences. 🙏
Reposted by Emma Doughty
Reposted by Emma Doughty
kgandersen.bsky.social
The spread of Mpox in Sierra Leone is unlike anything we have ever seen - and we have been keeping an eye on this bug in the region for >15 years.

Given geographical spread, 50/50 men vs women, this is no "sexual network".

This could be the next one.

clt.npha.gov.sl/outbreak.aspx
emmadoughty.bsky.social
Really pleased to see this! Helps to address such a critical question for genomic interpretation

Well done, @katholt.bsky.social et al!
katholt.bsky.social
Excited to share the first beta release of AMRrules at #ABPHM! (Poster 42 tonight)
interpretamr.github.io/AMRrules
Reposted by Emma Doughty
drtedros.who.int
It's official: the #PandemicAccord is officially adopted by the World Health Assembly!

My warmest congratulations to @who.int Member States for their commitment to keeping their people and the world safer.

What a moment in global health history. Together!
emmadoughty.bsky.social
All the best, Alan. Your leadership at MK had a huge impact, both on the scale of national testing and for all the other folks in the lab during pretty tough times. I was glad to be there with you. Thank you for making your voice heard in the inquiry
Reposted by Emma Doughty
arambaut.bsky.social
Have said before that conference organisers when deciding on a host country should consider how easy it is for people to get visas (particularly for those from the Global South). For example, applying for a Canadian visa from the UK takes 344 days (www.canada.ca/en/immigrati...).
Reposted by Emma Doughty
kyrafreestar.bsky.social
Hello, I'm always trying to spread the word about the Academic Editing Circle, which organizes professional editors to volunteer time for Black and/or Indigenous scholars.

I can't promise that a volunteer can donate time for a whole book-length dissertation, but maybe we can help.
emmadoughty.bsky.social
A must-read for anyone doing Global North-South work: Ways to level the highly unequal playing field

"the African academic is spending
their precious time contributing to your success. How are you contributing to theirs?"
boghuma.bsky.social
Fantastic read.A compelling behind the scenes look of realities that scholars based in Africa face when collaborating w colleagues based in the Global North. Also offers advice on building more ethical collaborations.
For everyone in global collaborative research.
www.tandfonline.com/doi/full/10....
“My Flight Arrives at 5 am, Can You Pick Me Up?”: The Gatekeeping Burden of the African Academic
Over the past decade, there has been increased awareness and discourse around the inequalities which structure North–South academic collaboration. The purpose of this discussion is to look at the o...
www.tandfonline.com
Reposted by Emma Doughty
rouhiroo.bsky.social
Another is to support getting journals into local, high quality networks like @scielo.org. Resources like Redalyc (Mexico), TCC Africa, etc. We shouldn't force non-English communities to index in "our" indices. #r2rconf
emmadoughty.bsky.social
Thanks, Sara. This is great. Are there any resources you can point to for providing this expertise on indexing?
emmadoughty.bsky.social
That's a lot of underheard important voices, and a lot of neglected areas of research/neglected populations. What do you think we can do to increase the visibility across these areas?
Reposted by Emma Doughty
wvschaik.bsky.social
Landmark paper claxon!

'Evaluating the economic and health impact of proactive genomic epidemiology in a hospital setting'

www.medrxiv.org/content/10.1...

Significant savings associated with proactive genomic epidemiology.
Figure 6:
Overall annual potential savings and costs by use of the proactive genomic epidemiology approach
The health economic assessment uncovered yearly net cost savings of approximately € 1·25 million if initiated IPC measures completely halt transmission of clinical isolates after the second patient. The reduction in costs is due to a lower rate of costs for non-MDRO (red) and MDRO (blue) infections, respectively as well as colonization with MDRO (green). The costs for non-MDRO infections (red) are made up of the additional days a patient has to spend in hospital due to the infection (7·8 days), multiplied by the costs per patient for an additional day in hospital (€325). The costs for the colonization with MDRO (green) is composed of the average number of days a patient spends in the hospital (4·6 days), multiplied by the extra-costs incurred per patient per day for the isolation of the patient (€325). The cost for MDRO infections (blue) results from the average number of days a patient with an MDRO infection has to spend in hospital (7·8 days) multiplied by the additional costs incurred per day by a patient with an MDRO infection (€650).
emmadoughty.bsky.social
Jeez, Alan. Don't remind me!